Analysts call $310 CSL target price in new report
SYDNEY: Biotech company CSL was upgraded to ‘buy’ by analysts at Citi Group ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
FEATURED
‘Critical point’ for Star says chair as inflection point reached
Pokies reforms hit parliament but full rollout still three years away
Star’s long-suffering lenders are starting to become very impatient
Kyle Rogers has job of turning loss making Flemington around
Victoria snatches pokie reform idea Tasmania dropped last week